Singer India Gets NSE Approval for Main Board Listing of 6.22 Crore Shares
Singer India Limited has secured NSE approval for main board listing of 6.22 crore equity shares with ₹2 face value, scheduled to commence trading on March 19, 2026 under ticker 'SINGERIND'. The approval includes 61,655,539 freely tradeable shares and 563,578 locked shares until August 9, 2026, positioning the company for improved market visibility and institutional investor access.

*this image is generated using AI for illustrative purposes only.
Singer India Limited has received formal approval from the National Stock Exchange (NSE) to list its equity shares on the main board, marking a significant corporate milestone. The approval covers 6.22 crore shares that will commence trading under the ticker symbol 'SINGERIND'.
Official Listing Approval
The NSE has granted approval for listing Singer India's equity shares with a face value of ₹2 each on the main board. The company has formally communicated this development to BSE Limited under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
| Parameter: | Details |
|---|---|
| Exchange: | National Stock Exchange (NSE) |
| Listing Type: | Main Board |
| Share Quantity: | 6.22 crore equity shares |
| Face Value: | ₹2 per share |
| Trading Start Date: | March 19, 2026 |
| Ticker Symbol: | SINGERIND |
| Series: | EQ |
| Market Lot: | 1 |
Share Structure and Trading Details
The total equity shares are divided into different categories based on lock-in periods. According to the NSE approval documentation, the majority of shares will be freely tradeable, while a portion will remain locked-in for a specified period.
| Share Category: | Quantity | Lock-in Period |
|---|---|---|
| Free Shares: | 61,655,539 | Immediate trading |
| Locked Shares: | 563,578 | Until August 9, 2026 |
| Total Shares: | 62,219,117 | - |
Market Impact and Corporate Significance
The main board listing will provide Singer India with enhanced market visibility and improved liquidity for its shares. This listing approval represents an important step in the company's capital market journey and positions it for better access to institutional investors and improved trading volumes.
The NSE approval was processed following completion of all regulatory requirements for the main board listing. Trading is scheduled to commence on March 19, 2026, marking Singer India's entry into the organized equity market segment.
How will Singer India's main board listing impact its ability to raise capital for expansion plans compared to its previous trading status?
What strategic initiatives might Singer India pursue with improved access to institutional investors following the NSE listing?
Will the enhanced market visibility from main board listing help Singer India compete more effectively against established players in its sector?
























